Levothyroxine Sodium Tablet
Product Images NDC 68071-3787

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 68071-3787). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (51ff81f2 92d7 4d05 92e4 04272f9447da 01)

Image-1 (51ff81f2 92d7 4d05 92e4 04272f9447da 01)
Chemical structure of Levothyroxine Sodium showing two iodinated benzene rings connected by an ether linkage, with a side chain containing an amino group, carboxylate group, and sodium ion associated with hydration.*
FDA Label Image

Pdp (68071 3787 9)

Pdp (68071 3787 9)
Label for Levothyroxine Sodium 200 mcg oral tablets from NuCare Pharmaceuticals, Inc. The label indicates a package of 90 tablets, each containing 200 mcg (0.2 mg) of Levothyroxine Sodium. Tablets are described as round, pink, scored, and debossed with 'L26' on one side and a break-line on the other. Storage instructions advise controlled temperature between 68-77°F. The label also shows NDC 68071-3787-9 and manufacturing details from Lupin Limited Pithampur, M.P., India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.